Research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued on Sunday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Shares of NASDAQ MTEX opened at $14.73 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. Mannatech has a one year low of $6.75 and a one year high of $15.25. The firm has a market capitalization of $27.77 million, a P/E ratio of -18.18 and a beta of 1.04. The company’s fifty day moving average is $9.92 and its two-hundred day moving average is $8.26.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Read More
- Five stocks we like better than Mannatech
- Investing In Automotive Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Best Aerospace Stocks Investing
- Nebius Group: The Rising Star in AI Infrastructure
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
